A detailed history of Brandywine Managers, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Brandywine Managers, LLC holds 10,073 shares of TXG stock, worth $147,770. This represents 0.25% of its overall portfolio holdings.

Number of Shares
10,073
Previous 10,073 -0.0%
Holding current value
$147,770
Previous $195,000 16.41%
% of portfolio
0.25%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$34.32 - $57.55 $38,953 - $65,319
-1,135 Reduced 10.13%
10,073 $563,000
Q3 2022

Nov 14, 2022

BUY
$28.48 - $52.59 $84,500 - $156,034
2,967 Added 36.0%
11,208 $319,000
Q1 2022

May 13, 2022

BUY
$55.7 - $145.79 $57,036 - $149,288
1,024 Added 14.19%
8,241 $627,000
Q1 2021

May 13, 2021

BUY
$140.25 - $196.86 $409,109 - $574,240
2,917 Added 67.84%
7,217 $1.31 Million
Q3 2019

Nov 13, 2019

BUY
$49.99 - $62.0 $214,957 - $266,600
4,300 New
4,300 $217,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.39B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Brandywine Managers, LLC Portfolio

Follow Brandywine Managers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Managers, LLC with notifications on news.